PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
155 hedge funds and large institutions have $522M invested in Progenics Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 152 → 155 (+3)
Holders
155
Holding in Top 10
1
Calls
$14.3M
Puts
$5.48M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$11.3M | |
| 3 | +$5.03M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.35M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.24M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$10.7M | |
| 3 | -$2.51M | |
| 4 |
JP Morgan Chase
New York
|
-$2.5M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$1.38M |